| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | Australia | 2 | |
| #3 | Brazil | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | United States | 2 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zwyer Alexander C | 8 |
| #2 | Schmith Virginia | 6 |
| #3 | Brantley Scott | 6 |
| #4 | Amsel Lewis P | 6 |
| #5 | Konofal Eric | 4 |
| #6 | Alexander C Zwyer | 3 |
| #7 | Zwyer Alexander | 2 |
| #8 | Virginia Schmith | 2 |
| #9 | Scott Brantley | 2 |
| #10 | Lewis P Amsel | 2 |
| Publication | Filing date | Title |
|---|---|---|
| CA3074054A1 | Mazindol treatment for heroin dependence and substance use disorder | |
| CA3016852A1 | A mazindol ir/sr multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (adhd) |